Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China
2018-08-09 17:05
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes
2018-08-09 16:16
TOT BIOPHARM raises US$102 million in Series B Financing Round
2018-08-08 19:00
VolitionRx Announces $9 Million Private Placement
2018-08-08 18:00
I-Mab Biopharma and MorphoSys Announce China IND Submission of TJ202/MOR202
2018-08-08 09:01
Ward MM and Adapt Analytics announce a partnership to integrate AI and machine learning into Ward MM's clinical decision support engine
2018-08-07 21:00
Adlai Nortye Announces Engagement of Lars E. Birgerson, M.D., Ph.D., as CDO and President/CEO of Adlai Nortye USA
2018-08-07 01:15
China Biologic Reports Financial Results for the Second Quarter of 2018
2018-08-04 04:30
IMPACT Therapeutics Raises $30 Million In Series C Financing
2018-08-03 16:48
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA
2018-08-01 18:52
I-Mab Biopharma Announces New CFO
2018-08-01 08:44
WuXi Biologics Commenced Process Validation in MFG2
2018-07-31 07:55
CStone's MEK Inhibitor CS3006 Receives IND Approval in China
2018-07-30 12:51
China Biologic Products to Report Second Quarter 2018 Financial Results
2018-07-27 20:00
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator
2018-07-26 19:30
WuXi STA's Jinshan Site Passes Fourth U.S. FDA Inspection
2018-07-26 08:00
OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing
2018-07-23 14:42
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China
2018-07-22 22:11
Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
2018-07-19 21:00
China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing
2018-07-17 19:00
1
138
139
140
141
142
165